RORA and cancer: In addition, it was shown that Cluster 1 (CRY2, PER1, and RORA) and TIMELESS exerted opposite impacts on interactive gene network, infiltration of immune cells, cancer-related signaling pathways, and cellular sensitivity to clinically used drugs.